Molnupiravir
- 2 independent labs in 2 countries
- Funders: Bezmialem Vakıf Üniversitesi and 2 more
- Animals1
- Model organisms1
Outcomes
2Lifespan
downin worms1
1 study
Lifespan
downin worms1
Molnupiravir shortens lifespan in worms.
“C. elegans exposed to higher concentrations of the drug (20-500 μM) exhibited significant lifespan reduction at all doses.”
Model organisms20-500 μM
International journal of toxicology9 Apr 2026
Respiratory sequelae
downin P. roborovskii1
1 study
Respiratory sequelae
downin P. roborovskii1
Molnupiravir prevents respiratory sequelae in P. roborovskii.
“Treatment of acute disease with approved antivirals, paxlovid-like nirmatrelvir + ritonavir or molnupiravir, prevented long-term respiratory sequelae in aged animals.”
Animalsacute SARS-CoV-2 infectionlung
Journal of virology11 Aug 2025
Latest
1 in 12 monthsInternational Journal of Toxicology
Sub-Cytotoxic Mitochondrial Stress in Cardiomyocytes and Whole-Organism Toxicity in C. elegans Induced by Molnupiravir
Experiments in wormsMitochondrion
Journal of Virology
SARS-CoV-2 causes chronic lung inflammation and impaired respiratory capacity in aged Roborovski dwarf hamsters
Experiments in animalsLung